The role of BMP4 signalling in oligodendrogenesis following central demyelination

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Multiple Sclerosis (MS) is the most common neurodegenerative disease affecting young adults. It is a disease that kills myelin cells, which are necessary support cells for neurons and are critical for their function. This research investigates the role that BMPs play in myelin cell production and repair. Our aim is to identify regenerative therapeutics for MS.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $360,202.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical infection agents (incl. prions)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell differentiation | demyelinating disease | multiple sclerosis | myelination | neural stem cell | neurodegeneration | oligodendrocyte | quality of life